MUDr. Zuzana Mrkvová
Department of Internal Medicine, Hematology and Oncology
e‑mail: |
---|
Total number of publications: 5
2023
-
Hodnocení minimální zbytkové choroby u nemocných s De Novo akutní myeloidní leukemií léčených kombinovanou terapií Azacitidine a Venetoclax.
Year: 2023, type: Conference abstract
2021
-
Loss of FADD and Caspases Affects the Response of T-Cell Leukemia Jurkat Cells to Anti-Cancer Drugs
International Journal of Molecular Sciences, year: 2021, volume: 22, edition: 5, DOI
2020
-
ALBENDAZOL A FENBENDAZOL SNIŽUJÍ EXPRESI MDM2 A MDMX A AKTIVUJÍ P53 V NÁDOROVÝCH LINIÍCH SE ZVÝŠENOU EXPRESÍ MDMX
Year: 2020, type: Conference abstract
2019
-
BENZIMIDAZOLES DOWNREGULATE MDM2 AND MDMX AND ACTIVATE P53 IN MDMX OVEREXPRESSING TUMOR CELL
Year: 2019, type: Conference abstract
-
Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
Molecules, year: 2019, volume: 24, edition: 11, DOI